Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5645534 | Annals of Allergy, Asthma & Immunology | 2017 | 6 Pages |
Abstract
The addition of misoprostol to current aspirin challenge and/or desensitization protocols reveals no protective effect in reducing the intensity of nonsteroidal anti-inflammatory drug-induced symptoms and is not recommended based on the findings in this study.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Kristen M. MD, Ronald A. MD, Katharine M. MD, Nathan E. PhD, Andrew A. MD,